Drugs and syringe drivers: a survery of adult specialist palliative care practice in the United Kingdom and Eire

O'Doherty, C.; Hall, E.; Schofield, L.; Zeppetella, G.
March 2001
Palliative Medicine;Mar2001, Vol. 15 Issue 2, p149
Academic Journal
Subcutaneous delivery of drugs using a syringe driver is common practice within specialist palliative care units. There is, however, little documented information regarding clinical practice. A survey performed in 1992 reported that at least 28 drugs were used in combination with others in a single syringe driver. The aim of the present study was to reassess practice in this field and to enquire more specifically about newer drugs. Postal questionnaires were sent to all adult specialist palliative care in-patient units in the UK and Eire (n=208). One hundred and sixty-five units (79%) responded. The most common syringe driver in use was the Graseby 26 (61% of responding units). Most units delivered the contents of the syringe over 24 h, and water was usually used as the diluent in 90% of cases. The maximum number of drugs that respondents were prepared to mix in a single syringe was usually three (51%) or four (35%). In the UK, all units used diamorphine in doses from 2.5 mg/24 h upwards. All respondents also used haloperidol, in doses from 0.5 to 60 mg/24 h. A total of 28 different drugs were used in syringe drivers. The most common combinations were diamorphine and midazolam (37%), diamorphine and levomepromazine (35%), diamorphine and haloperidol (33%), and diamorphine and cyclizine (31%). In conclusion, there is much in common with regard to the way in which drugs are delivered in syringe drivers. However, a wide variety of drugs and drug combinations are still in use.


Related Articles

  • Infusion pumps in palliative care are vital, but many need updating. Lorenzl, Stefan // British Journal of Nursing;9/26/2013 Supplement, Vol. 22 Issue 17, pS4 

    In this article the author discusses infusion pumps which are used in health care facilities to deliver medications to patients subcutaneously. He is supportive of using infusion pumps but suggests that medical professionals need to pay close attention to the dosage of drugs which are used in...

  • The Nordic Specialist Course in Palliative Medicine: evaluation and experiences from the first course 2003-2005. Haugen, D. F.; Vejlgaard, T. // Palliative Medicine;Apr2008, Vol. 22 Issue 3, p256 

    Background and aims: Palliative medicine is not recognized as a medical specialty in any of the five Nordic countries, but there is a great need for physicians with specialty qualifications to serve on an increasing number of palliative care services. The Associations for Palliative Medicine in...

  • A phase II study of Yondelis (trabectedin, ET-743) as a 24-h continuous intravenous infusion in pretreated advanced breast cancer. Zelek, L.; Yovine, A.; Brain, E.; Turpin, F.; Taamma, A.; Riofrio, M.; Spielmann, M.; Jimeno, J.; Misset, J. L. // British Journal of Cancer;6/5/2006, Vol. 94 Issue 11, p1610 

    Yondelis® (trabectedin, ET-743) is a novel marine-derived anticancer compound found in the ascidian Ecteinascidia turbinata. It is currently under phase II/III development in breast cancer, hormone refractory prostate cancer, sarcomas and ovarian cancer. Activity in breast cancer experimental...

  • Patients' psychosocial experiences of attending Specialist Palliative Day Care: A systematic review. Bradley, Sarah E; Frizelle, Dorothy; Johnson, Miriam // Palliative Medicine;Apr2011, Vol. 25 Issue 3, p210 

    Recent reviews conclude that the benefits of attending Specialist Palliative Day Care (SPDC) are likely to be in social, psychological and spiritual domains. However, these areas are not easily identified, leaving researchers and practitioners unclear as to what aspects of these domains patients...

  • A physician's life is intense, in all specialties. McSweeny, Linda // Medical Journal of Australia;10/17/2011, Vol. 195 Issue 8, p439 

    The article reports on the results of a 2011 study which indicated that the intensity of the work of physicians are equal in all medical specialties.

  • Physician numbers hold steady.  // CMAJ: Canadian Medical Association Journal;01/27/98, Vol. 158 Issue 2, p161 

    Reports on the number of physicians in Canada. Statistics from the Canadian Institute for Health Information; The decline in number for 1996; The number of specialists in Canada in 1996; Physician-patient ratio.

  • MATERIA NON MEDICA. Goldman, Myer; Paton, Alex; Drife, James Owen // British Medical Journal (Clinical Research Edition);2/21/1981, Vol. 282 Issue 6264, p627 

    Relates the experiences of medical specialists in Great Britain. Views on giving credit to the efforts of individuals; Description of a tennis court; Experiences of a lecturer about a fire in the neighborhood.

  • Budget, White Paper, manpower, and waiting lists. Russell, William // British Medical Journal (Clinical Research Edition);3/21/1981, Vol. 282 Issue 6268, p1004 

    Focuses on different difficulties in the medical professions. Removal of tax charges on medical insurance premium paid by some employers; Benefits of the employees from the medical insurance; Publication of the Public Expenditure White Paper by the government.

  • Medical stereotypes. Harris, C.M. // British Medical Journal (Clinical Research Edition);12/19/1981, Vol. 283 Issue 6307, p1676 

    Examines the viewpoints of medical students toward the attitude of medical specialist in Manchester, England. Comparison on the characteristics of medical specialists; Similarity on the opinions of the students; Citations on studies concerning stereotypes of specialists.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics